PBP's R&D facilities located in the Biomedical Park of Singapore boast well-equipped multidisciplinary research infrastructure, supporting pharmaceutical R&D activities from discovery to nonclinical and clinical development. Read More
Prestige BioPharma Pte Ltd
Prestige BioPharma focuses on discovery and development of innovative new biologics as well as biosimilars.
PBP's first biosimilar HD201, Trastuzumab, successfully completed Phase I clinical trial in EU in 2014 and currently under Phase III development.
PBP thrives to become one of the top biopharmaceuticals specializing in discovery of new biologics and next series of biosimilars.
"Creating Difference & Value for Human Health"
15 Tech Park Crescent Singapore Singapore 638117 Phone: +65.68639575 E-mail: email@example.com
News & Resources